RA therapy (KaloBios)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameRA therapy (KaloBios)
Drug Alias NameRA antibody (KaloBios)arthritis antibody (KaloBios)autoimmune disease therapy (KaloBios)rheumatoid arthritis therapy (KaloBios)autoimmune disease antibody (KaloBios) +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLudwig Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLudwig Institute For Cancer ResearchHumanigen Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A